Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

19
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
19
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

28
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
28
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.9K
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

26
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
26
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

25
Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through...
25
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

1.8K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elexacaftor/Tezacaftor/Ivacaftor as a Bridge to Lung Retransplant in a Recipient With Cystic Fibrosis.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2022
Same author

Management of ganciclovir resistance cytomegalovirus infection with CMV hyperimmune globulin and leflunomide in seven cardiothoracic transplant recipients and literature review.

Transplant infectious disease : an official journal of the Transplantation Society·2021
Same author

Airway-centered Interstitial Fibrosis: An Unusual Presentation.

The Indian journal of chest diseases & allied sciences·2018
Same author

Diagnosis at a glance of radiological imaging.

The Indian journal of tuberculosis·2017
Same author

Asymptomatic Unilateral Hyperlucent Lung in a Prospective Kidney Donor.

The Journal of the Association of Physicians of India·2016
Same author

Hydatid Cyst Presenting With Endobronchial Rupture.

The Indian journal of chest diseases & allied sciences·2016
Same journal

Ethical challenges in community-based tuberculosis screening and surveillance.

The Indian journal of tuberculosis·2026
Same journal

Effectiveness of e-learning modules in community-based tuberculosis awareness programs.

The Indian journal of tuberculosis·2026
Same journal

Role of digital media campaigns in improving TB health literacy at the community level.

The Indian journal of tuberculosis·2026
Same journal

Digital case-based learning for improving clinical decision-making in tuberculosis care.

The Indian journal of tuberculosis·2026
Same journal

Simulation and virtual reality applications in medical training for tuberculosis diagnosis.

The Indian journal of tuberculosis·2026
Same journal

Use of tele-education for strengthening community participation in tuberculosis control.

The Indian journal of tuberculosis·2026
See all related articles

Related Experiment Video

Updated: Apr 23, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

1.3K

Bilateral upper lobe lung fibrosis.

Kapil Iyer, Vinaya Karkhanis, J M Joshi

    The Indian Journal of Tuberculosis
    |September 23, 2014
    PubMed
    Summary
    This summary is machine-generated.

    A man diagnosed with bilateral upper lobe fibrosis, initially suspected as tuberculosis, was found to have Marfan syndrome. This highlights the importance of thorough evaluation for rare connective tissue disorders.

    More Related Videos

    Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
    03:38

    Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models

    Published on: June 20, 2025

    1.1K
    Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
    06:03

    Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

    Published on: May 9, 2025

    2.1K

    Related Experiment Videos

    Last Updated: Apr 23, 2026

    Refined Murine Model of Idiopathic Pulmonary Fibrosis
    07:51

    Refined Murine Model of Idiopathic Pulmonary Fibrosis

    Published on: June 17, 2025

    1.3K
    Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
    03:38

    Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models

    Published on: June 20, 2025

    1.1K
    Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
    06:03

    Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

    Published on: May 9, 2025

    2.1K

    Area of Science:

    • Cardiology
    • Pulmonology
    • Genetics

    Background:

    • Fibrotic lung disease can present with bilateral upper lobe involvement.
    • Tuberculosis is a common cause of upper lobe lung fibrosis.
    • Marfan syndrome is a genetic connective tissue disorder with diverse clinical manifestations.

    Observation:

    • A 33-year-old man presented with bilateral upper lobe fibrosis on chest X-ray.
    • The initial diagnosis considered tuberculosis as the cause of the lung findings.
    • The patient was denied a work permit based on these findings.

    Findings:

    • Detailed medical evaluation revealed the bilateral upper lobe fibrosis was not due to tuberculosis.
    • The etiology of the lung fibrosis was identified as Marfan syndrome.
    • This case underscores Marfan syndrome's potential pulmonary manifestations.

    Implications:

    • Misdiagnosis of lung conditions can occur if underlying genetic disorders are not considered.
    • Early identification of Marfan syndrome is crucial for timely management and prevention of complications.
    • This case emphasizes the need for comprehensive diagnostic approaches in pulmonology and cardiology referrals.